Homocysteine levels in patients with schizophrenia on clozapine monotherapy

Neurochemical Research

Volumn 38, Issue 10, 2013, Pages 2056-2062

  Wysokiński, Adam ^a   Kłoszewska, Iwona ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Clozapine; Homocysteine; Schizophrenia

Indexed keywords

ALBUMIN; CALCIUM ION; CHOLESTEROL; CLOZAPINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BASAL METABOLIC RATE; BODY COMPOSITION; BODY FAT; BODY WATER; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LEAN BODY WEIGHT; MALE; MONOTHERAPY; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BODY COMPOSITION; CLOZAPINE; FEMALE; HEALTHY VOLUNTEERS; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; WAIST CIRCUMFERENCE;

EID: 84884901727     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1113-1     Document Type: Article

References (28)

1. Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G (2009) Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev CD006612
2. Neeman G, Blanaru M, Bloch B, Kremer I, Ermilov M, Javitt DC, Heresco-Levy U (2005) Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type. Am J Psychiatry 162:1738-1740
3. McEvoy JP, Meyer JM, Goff DC et al (2005) Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 80:19-32
4. Selhub J (2006) The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 136:1726S-1730S
5. Saedisomeolia A, Djalali M, Moghadam AM, Ramezankhani O, Najmi L (2011) Folate and vitamin B12 status in schizophrenic patients. J Res Med Sci 16(Suppl 1):S437-S441
6. Lee YS, Han DH, Jeon CM, Lyoo IK, Na C, Chae SL, Cho SC (2006) Serum homocysteine, folate level and methylenetetrahydrofolate reductase 677, 1298 gene polymorphism in Korean schizophrenic patients. NeuroReport 17:743-746
7. Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137-146
8. Dietrich-Muszalska A, Malinowska J, Olas B, Glowacki R, Bald E, Wachowicz B, Rabe-Jablonska J (2012) The oxidative stress may be induced by the elevated homocysteine in schizophrenic patients. Neurochem Res 37:1057-1062
9. Ho PI, Ortiz D, Rogers E, Shea TB (2002) Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 70:694-702
10. Lerner V, Miodownik C, Kaptsan A, Vishne T, Sela BA, Levine J (2005) High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesia. J Clin Psychiatry 66:1558-1563
11. Levine J, Stahl Z, Sela BA et al (2006) Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia. Biol Psychiatry 60:265-269
12. Kane JM (2012) Addressing nonresponse in schizophrenia. J Clin Psychiatry 73:e07
13. Newcomer JW (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19(Suppl 1):1-93
14. Auquier P, Lancon C, Rouillon F, Lader M, Holmes C (2006) Mortality in schizophrenia. Pharmacoepidemiol Drug Saf 15:873-879
15. Iqbal MM, Rahman A, Husain Z, Mahmud SZ, Ryan WG, Feldman JM (2003) Clozapine: a clinical review of adverse effects and management. Ann Clin Psychiatry 15:33-48
16. Okamura N, Hashimoto K, Kanahara N, Shimizu E, Kumakiri C, Komatsu N, Iyo M (2003) Protective effect of the antipsychotic drug zotepine on dizocilpine-induced neuropathological changes in rat retrosplenial cortex. Eur J Pharmacol 461:93-98
17. Magliaro BC, Saldanha CJ (2009) Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation. Brain Res 1283:14-24
18. Moller M, Du Preez JL, Emsley R, Harvey BH (2011) Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administration. Eur Neuropsychopharmacol 21:471-483
19. Fehsel K, Loeffler S, Krieger K, Henning U, Agelink M, Kolb-Bachofen V, Klimke A (2005) Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients. J Clin Psychopharmacol 25:419-426
20. Bosy-Westphal A, Later W, Hitze B et al (2008) Accuracy of bioelectrical impedance consumer devices for measurement of body composition in comparison to whole body magnetic resonance imaging and dual X-ray absorptiometry. Obes Facts 1:319-324
21. Levine J, Stahl Z, Sela BA, Gavendo S, Ruderman V, Belmaker RH (2002) Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry 159:1790-1792
22. Henderson DC, Copeland PM, Nguyen DD et al (2006) Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophrenia. Acta Psychiatr Scand 113:121-125
23. Sanchez-Margalet V, Valle M, Ruz FJ, Gascon F, Mateo J, Goberna R (2002) Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem 13:75-79
24. Esteghamati A, Mousavizadeh M, Noshad S, Shoar S, Khalilzadeh O, Nakhjavani M (2012) Accuracy of anthropometric parameters in identification of high-risk patients predicted with cardiovascular risk models. Am J Med Sci [Epub ahead of print]
25. Bjorntorp P (1988) The associations between obesity, adipose tissue distribution and disease. Acta Med Scand Suppl 723:121-134
26. Lin YH, Pao KY, Yang WS et al (2008) Waist-to-hip ratio correlates with homocysteine levels in male patients with coronary artery disease. Clin Chem Lab Med 46:125-130
27. Battezzati A, Bertoli S, San Romerio A, Testolin G (2007) Body composition: an important determinant of homocysteine and methionine concentrations in healthy individuals. Nutr Metab Cardiovasc Dis 17:525-534
28. Abbasi F, Facchini F, Humphreys MH, Reaven GM (1999) Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis 146:175-178